Ofer Yossepowitch - Concepedia

Author

Ofer Yossepowitch

Tel Aviv University ORCID

Also Known As

O Yossepowitch, O. Yossepowitch, O., Yossepowitch, OFER YOSSEPOWITCH, Ofer Yossepowitch, Yossepowitch, Ofer

238

Publications

7.1K

Citations

H-Index

Concepts

All Affiliations

Tel Aviv University Rabin Medical Center Memorial Sloan Kettering Cancer Center Tel Aviv Sourasky Medical Center

About

Ofer Yossepowitch is an author at Tel Aviv University specializing in medicine, urology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	1.2K
2	Health Sciences	3	3	100
3	Diabetes	1	1	48
4	Diagnostic Sciences	1	1	38
5	Endocrinology	1	1	48

Ofer Yossepowitch

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy Scott E. Eggener, Peter T. Scardino, Patrick C. Walsh, The Journal of Urology	2011	639
Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era Andrew J. Stephenson, Michael W. Kattan, James A. Eastham, Journal of Clinical Oncology	2009	417
Positive Surgical Margins at Partial Nephrectomy: Predictors and Oncological Outcomes Ofer Yossepowitch, R. Houston Thompson, Bradley C. Leibovich, The Journal of Urology	2008	290
Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence Scott E. Eggener, Ofer Yossepowitch, Joseph A. Pettus, Journal of Clinical Oncology	2006	287
Radical Prostatectomy for Clinically Localized, High Risk Prostate Cancer: Critical Analysis of Risk Assessment Methods Ofer Yossepowitch, Scott E. Eggener, Fernando J. Bianco, The Journal of Urology	2007	229
Positive Surgical Margins in Soft Tissue Following Radical Cystectomy for Bladder Cancer and Cancer Specific Survival Zohar Dotan, K.L. Kavanagh, Ofer Yossepowitch, The Journal of Urology	2007	227
Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 with <sup>18</sup>F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard Jonathan Kuten, Ibrahim Fahoum, Ziv Savin, Journal of Nuclear Medicine	2019	213
Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy Ofer Yossepowitch, Scott E. Eggener, Angel M. Serio, European Urology Metastatic ProgressionUrologySurgical OncologyGenitourinary CancerMedicine	2007	190
PREDICTING THE SUCCESS OF RETROGRADE STENTING FOR MANAGING URETERAL OBSTRUCTION Ofer Yossepowitch, David Lifshitz, Yoram Dekel, The Journal of Urology	2001	160
Risk Score and Metastasectomy Independently Impact Prognosis of Patients With Recurrent Renal Cell Carcinoma Scott E. Eggener, Ofer Yossepowitch, Shilajit Kundu, The Journal of Urology	2008	144

Page 1